{"id":875773,"date":"2025-08-14T10:21:31","date_gmt":"2025-08-14T14:21:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/"},"modified":"2025-08-14T10:21:31","modified_gmt":"2025-08-14T14:21:31","slug":"aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","title":{"rendered":"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech"},"content":{"rendered":"<h2>\nLive video webcast on Wednesday, August 20th at 2:40 PM ET\u00a0\u00a0<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">OCALA, Fla., Aug.  14, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G7HuS6A2C0NBRNopV7hHfu7Tq_jndllFVtHEvlK0GxSssTvTQ6qhw-Nclv4RUYNCT8GHgXT4vYHDDaCcksizTKXfexSqssvkNJgfJSpGvK0=\" rel=\"nofollow\" target=\"_blank\"><strong>AIM ImmunoTech Inc.<\/strong><\/a><strong> (NYSE American: AIM)\u00a0<\/strong>(\u201cAIM\u201d or the \u201cCompany\u201d), today announced that it will present at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=387GEh7gSAGwSc30DYHsOFl6gQKS8Y2imXpJCjUUnYSx7BquomBO9tetXXpDFTgEG1GoL-HgAOr24fO3_diYtFCdapk6BI8IHErz356Y3CtNVdRI_vWMkCHWRsHkBUHROTtRLGMJvyS2Jq_p1p5j23bbmiAuu1xLXyp3z8HFDE4=\" rel=\"nofollow\" target=\"_blank\">Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech<\/a> being held virtually August 19-21, 2025.<\/p>\n<p>Details for the presentation are as follows:<\/p>\n<p>\n        <strong>Date and Time:<\/strong> Wednesday, August 20, 2025 at 2:40 PM ET <br \/><strong>Presenter:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CDi-jzL1Z9HcLeuL2qcucUwvS-nHmStQClKeZhwhEBsBjMVDNvq5un4VX4wl1-4aNuhP14pqiFHfgwbEylxuI2yHuVBo_dTXhfXtvvSd_TVU2K8NFxCpM4Kvfp2ZOo4EelO78GodpfjnR5cBgNR7Otp-9fOejlmpcnG__Q_fA7kWmqkhJ6HIM95J-QRrP9JL\" rel=\"nofollow\" target=\"_blank\">Thomas Equels, Chief Executive Officer, President &amp; Executive Vice Chairman<\/a><br \/><strong>Registration Link:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=387GEh7gSAGwSc30DYHsOOsfPsPtNlqc9MGXOtOtdrbY_2elZt6-sZKTSLcjKjnINYDmeffQd6M4HapzjrNLKB6WkXWTa_VnKgUhjlyZ2Cg=\" rel=\"nofollow\" target=\"_blank\">Webull Webinars<\/a><\/p>\n<p>\n        <strong>About Webull Financial <\/strong>\n      <\/p>\n<p align=\"justify\">Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing the way individuals approach investing. The user-centric approach and commitment to staying at the forefront of industry trends underscore the mission to provide a seamless and rewarding experience for traders of all levels. Through the Webull Group, Webull Financial and its affiliates combine to serve tens of millions of users from over 180 countries worldwide. Securities and futures trading is offered to customers by Webull Financial LLC (&#8220;Webull Financial&#8221;), a broker-dealer registered with the Securities and Exchange Commission (SEC) and a futures commission merchant registered with the Commodity Futures Trading Commission (CFTC). Webull Financial is a member of the Financial Industry Authority (FINRA), the National Futures Association (NFA), and the Securities Investor Protection Corporation (SIPC). All investing is subject to risk, including the possible loss of principal. For more information about Webull, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mTCkuc3WIw4xHuch5KEMSd1DJl6b10fNEAEHt-VjWvXjSpvLL9EoMhvsplE_S6OgCmy2CTQFRZhwoh24jl77dg==\" rel=\"nofollow\" target=\"_blank\">www.webull.com<\/a>.<\/p>\n<p>\n        <strong>About AIM ImmunoTech Inc.<\/strong><br \/>\n        \n      <\/p>\n<p align=\"justify\">AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company\u2019s lead product is a first-in-class investigational drug called Ampligen<sup>\u00ae<\/sup>\u00a0(rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.<\/p>\n<p align=\"justify\">For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eszXPZY665KBR2n5_H1gZAfJ_6ofvcdhI1CYlstMX21T0littYJof71WkLR64lpdw6JwXGioLMTA7-WgXHCmqw==\" rel=\"nofollow\" target=\"_blank\">aimimmuno.com<\/a>\u00a0and connect with the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SMstSg3I7-CZWYSVsK6n6RxUDu9UTao2WcXAabGTP_rSmo7z-UwrFQfPXxZUOf1DSfFhfW_xGJTu1fM8bR_Trg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sEy2oFKGLSZ1aMhfHmihmcXao2nfihj1dWBBbalGYlmAJfZQBOt0eulYuDYB7YfTzxQ9ao0VnPiHIXeGjydXx2JK6udd9Z4dEDcwIlNhPS-k6shZ5PscNY6K4Rr2rj9O\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6EkorblRuQ3kufBCqHBFfi6Esq-mLiCqwtNj5ini7rO-jWbBrxxqj3N5lGXvCjUH7PFM3SlcaLqW9C5vCn9ZkjZaQmMdmDNevesdW8NDO3c=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDdjZjhiMjctNWZlNC00ZTUwLWIzMWEtNTZiZmZkOWE3ZjUyLTEwMzQ3MzUtMjAyNS0wOC0xNC1lbg==\/tiny\/AIM-ImmunoTech-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact:\r\n\r\nJTC Team, LLC\r\nJenene Thomas\r\n908.824.0775\r\nAIM@jtcir.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Live video webcast on Wednesday, August 20th at 2:40 PM ET\u00a0\u00a0 OCALA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) &#8212; AIM ImmunoTech Inc. (NYSE American: AIM)\u00a0(\u201cAIM\u201d or the \u201cCompany\u201d), today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:40 PM ET Presenter:Thomas Equels, Chief Executive Officer, President &amp; Executive Vice ChairmanRegistration Link:Webull Webinars About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-875773","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Live video webcast on Wednesday, August 20th at 2:40 PM ET\u00a0\u00a0 OCALA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) &#8212; AIM ImmunoTech Inc. (NYSE American: AIM)\u00a0(\u201cAIM\u201d or the \u201cCompany\u201d), today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:40 PM ET Presenter:Thomas Equels, Chief Executive Officer, President &amp; Executive Vice ChairmanRegistration Link:Webull Webinars About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing &hellip; Continue reading &quot;AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-14T14:21:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\\\/MedTech\",\"datePublished\":\"2025-08-14T14:21:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\"},\"wordCount\":356,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\",\"name\":\"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\\\/MedTech - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=\",\"datePublished\":\"2025-08-14T14:21:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\\\/MedTech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","og_locale":"en_US","og_type":"article","og_title":"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk","og_description":"Live video webcast on Wednesday, August 20th at 2:40 PM ET\u00a0\u00a0 OCALA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) &#8212; AIM ImmunoTech Inc. (NYSE American: AIM)\u00a0(\u201cAIM\u201d or the \u201cCompany\u201d), today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:40 PM ET Presenter:Thomas Equels, Chief Executive Officer, President &amp; Executive Vice ChairmanRegistration Link:Webull Webinars About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing &hellip; Continue reading \"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-14T14:21:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech","datePublished":"2025-08-14T14:21:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/"},"wordCount":356,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","name":"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=","datePublished":"2025-08-14T14:21:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjI0NSM3MDk5MDE5IzIwMjMxNjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/875773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=875773"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/875773\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=875773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=875773"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=875773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}